Profil
Jean-Marc Roelandt formerly worked at SGKBB Ltd., as Chief Financial Officer & Executive Director, BHF Kleinwort Benson Group SA, as Managing Director from 2010 to 2016, Ubizen NV, as Chief Financial Officer from 1999 to 2005, MDxHealth SA, as Chief Financial Officer & Executive Vice President from 2017 to 2019, Ernst & Young Belgium, as Audit Manager, and Biocartis Group NV, as Chief Financial Officer.
Mr. Roelandt received his graduate degree from Ghent University.
Anciens postes connus de Jean-Marc Roelandt
| Sociétés | Poste | Fin |
|---|---|---|
| BIOCARTIS GROUP NV | Directeur Financier/CFO | 04/08/2023 |
| MDXHEALTH SA | Directeur Financier/CFO | 19/02/2019 |
| BHF KLEINWORT BENSON | Directeur Financier/CFO | 08/01/2014 |
Ubizen NV
Ubizen NV Information Technology ServicesTechnology Services Provides internet security solutions | Directeur Financier/CFO | 01/01/2005 |
SGKBB Ltd.
SGKBB Ltd. Investment ManagersFinance SGKBB invests in global bonds and equities, seeking to maximize returns while actively controlling risk. They are a bottom-up global equity manager which emphasizes selecting growth companies where the valuation is not considered excessive relative to the markets. Their primary investment focus is on the UK. The firm offers mainly growth-oriented asset management products and manages a diversified portfolio of international securities including emerging markets. | Directeur Financier/CFO | - |
Formation de Jean-Marc Roelandt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
SGKBB Ltd.
SGKBB Ltd. Investment ManagersFinance SGKBB invests in global bonds and equities, seeking to maximize returns while actively controlling risk. They are a bottom-up global equity manager which emphasizes selecting growth companies where the valuation is not considered excessive relative to the markets. Their primary investment focus is on the UK. The firm offers mainly growth-oriented asset management products and manages a diversified portfolio of international securities including emerging markets. | Finance |
Ubizen NV
Ubizen NV Information Technology ServicesTechnology Services Provides internet security solutions | Technology Services |
MDxHealth SA
MDxHealth SA Medical SpecialtiesHealth Technology Develops and commercializes epigenetic tests & services for cancer assessment | Health Technology |
Ernst & Young Belgium
Ernst & Young Belgium Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
BHF Kleinwort Benson Group SA
BHF Kleinwort Benson Group SA Investment ManagersFinance Provides financial services | Finance |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biocartis Group NV
Biocartis Group NV Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
















